Press Digest: Financial Times - October 22
PRESS DIGEST-Financial Times - October 22 Oct 22 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.
Headlines
-Elon Musk sets lower sales target for Tesla as it explores SpaceX merger
-Buyout firm EQT acquires German diagnostics group in €10.8bn deal
-Meta agrees deal to keep Mark Zuckerberg in California despite wealth tax proposal
-CVC explores bid for Verisure just one year after IPO
Overview
-Tesla TSLA.O lowered its annual sales aspirations of 20 million vehicles to 5 million, ahead of the carmaker's possible merger with SpaceX SPCX.O and aligning with Elon Musk's strategic pivot away from cars to robotics and AI.
-Sweden's EQT EQTAB.ST will buy molecular testing company Qiagen QIA.DE for about €9.6 billion, marking one of the largest take-private transactions in Europe this year.
-Meta META.O has agreed to a deal with Mark Zuckerberg to let him get non-voting shares he can sell to potentially foot a multi-billion-dollar tax bill in case a wealth tax is approved, in exchange for a commitment to remain a resident of California.
- Buyout firm CVC CVC.AS is exploring a bid to take Swedish security firm Verisure VSURE.ST private, less than a year after private equity firm Hellman & Friedman took it public in one of Europe’s highest-profile IPOs.
(Compiled by Bengaluru newsroom; Edited by Ronojoy Mazumdar)
Recent news on QIAGEN
See all newsLab testing LBO offers murky result for both sides
Deals of the day-Mergers and acquisitions
Press Digest: Financial Times - October 22
Brief: Qiagen And Eqt Private Equity Announce Agreement On A Recommended Voluntary All-Cash Public Takeover Offer
EQT to buy molecular testing firm Qiagen for $10.8 billion (updated)